BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8103676)

  • 21. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
    Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
    Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immunohistochemical analysis of heat shock protein 70, p53, and estrogen receptor status in carcinoma of the uterine cervix.
    Park CS; Joo IS; Song SY; Kim DS; Bae DS; Lee JH
    Gynecol Oncol; 1999 Jul; 74(1):53-60. PubMed ID: 10385551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
    Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
    Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.
    Furihata M; Inoue K; Ohtsuki Y; Hashimoto H; Terao N; Fujita Y
    Cancer Res; 1993 Oct; 53(20):4823-7. PubMed ID: 8402668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas.
    de Krijger RR; van der Harst E; van der Ham F; Stijnen T; Dinjens WN; Koper JW; Bruining HA; Lamberts SW; Bosman FT
    J Pathol; 1999 May; 188(1):51-5. PubMed ID: 10398140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix.
    Horn LC; Lindner K; Szepankiewicz G; Edelmann J; Hentschel B; Tannapfel A; Bilek K; Liebert UG; Richter CE; Einenkel J; Leo C
    Int J Gynecol Pathol; 2006 Apr; 25(2):182-6. PubMed ID: 16633070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inter-observer variation of p53 immunohistochemistry--an assessment of a practical problem and comparison with other studies.
    Kay EW; Barry Walsh CJ; Whelan D; O'Grady A; Leader MB
    Br J Biomed Sci; 1996 Jun; 53(2):101-7. PubMed ID: 8757686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53, c-erbB-2 and p21ras expression in tumor effusion cells of patients with histopathologically different ovarian neoplasms.
    Harłozińska A; Bar JK; Sobańska E; Goluda M
    Anticancer Res; 1997; 17(5A):3545-52. PubMed ID: 9413200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.
    Wang X; Jones TD; Maclennan GT; Yang XJ; Lopez-Beltran A; Eble JN; Koch MO; Lin H; Baldridge LA; Tretiakova M; Cheng L
    Anticancer Res; 2005; 25(3B):2001-4. PubMed ID: 16158936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Undifferentiated carcinoma: an immunohistochemical and ultrastructural study.
    Suo Z; Qvist H; Su W; Holm R; Giercksky KE; Nesland JM
    Anticancer Res; 1993; 13(3):643-9. PubMed ID: 8317892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
    Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas.
    Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
    Cancer Res; 1996 Mar; 56(6):1184-8. PubMed ID: 8640794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection.
    Lambkin HA; Mothersill CM; Kelehan P
    J Pathol; 1994 Jan; 172(1):13-8. PubMed ID: 7931822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical co-expression of c-erbb-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast.
    Sharma BK; Ray A; Kaur S; Gupta S
    Indian J Exp Biol; 1999 Mar; 37(3):223-7. PubMed ID: 10641149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
    Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
    Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
    Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive staining for p53 and expression of c-erbB-2 in endosalpinx hyperplasia: analysis of 48 cases and review of literature.
    Rabczyński JK; Kochman AT
    Neoplasma; 1999; 46(1):31-4. PubMed ID: 10355531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.